<VariationArchive VariationID="15413" VariationName="NM_000518.5(HBB):c.25_26del (p.Lys9fs)" VariationType="Deletion" Accession="VCV000015413" Version="117" RecordType="classified" NumberOfSubmissions="18" NumberOfSubmitters="18" DateLastUpdated="2024-07-29" DateCreated="2013-04-04" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="30452" VariationID="15413">
      <GeneList>
        <Gene Symbol="HBB" FullName="hemoglobin subunit beta" GeneID="3043" HGNC_ID="HGNC:4827" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5225464" stop="5227071" display_start="5225464" display_stop="5227071" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="5246695" stop="5248300" display_start="5246695" display_stop="5248300" Strand="-" />
          </Location>
          <OMIM>141900</OMIM>
        </Gene>
        <Gene Symbol="LOC106099062" FullName="HBB recombination region" GeneID="106099062" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5226570" stop="5228834" display_start="5226570" display_stop="5228834" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC107133510" FullName="origin of replication at HBB" GeneID="107133510" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5222166" stop="5229620" display_start="5222166" display_stop="5229620" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000518.5(HBB):c.25_26del (p.Lys9fs)</Name>
      <CanonicalSPDI>NC_000011.10:5226995:TT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p15.4</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5226996" stop="5226997" display_start="5226996" display_stop="5226997" variantLength="2" positionVCF="5226995" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="5248226" stop="5248227" display_start="5248226" display_stop="5248227" variantLength="2" positionVCF="5248225" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>cd8-AA</Name>
        <Name>CD 8 (-AA)</Name>
      </OtherNameList>
      <ProteinChange>K9fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1232" sequenceAccession="LRG_1232">
            <Expression>LRG_1232:g.5075_5076del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.5226996_5226997del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.5226996_5226997del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.5248226_5248227del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.5248226_5248227del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_000007.3" sequenceAccession="NG_000007" sequenceVersion="3" change="g.70619_70620del">
            <Expression>NG_000007.3:g.70619_70620del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_042296.1" sequenceAccession="NG_042296" sequenceVersion="1" change="g.527_528del">
            <Expression>NG_042296.1:g.527_528del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_046672.1" sequenceAccession="NG_046672" sequenceVersion="1" change="g.4931_4932del">
            <Expression>NG_046672.1:g.4931_4932del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_059281.1" sequenceAccession="NG_059281" sequenceVersion="1" change="g.5075_5076del">
            <Expression>NG_059281.1:g.5075_5076del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000518.5" sequenceAccession="NM_000518" sequenceVersion="5" change="c.25_26del" MANESelect="true">
            <Expression>NM_000518.5:c.25_26del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000509.1" sequenceAccession="NP_000509" sequenceVersion="1" change="p.Lys9fs">
            <Expression>NP_000509.1:p.Lys9fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1232t1" sequenceAccession="LRG_1232t1">
            <Expression>LRG_1232t1:c.25_26del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1232p1" sequenceAccession="LRG_1232p1" change="p.Lys9fs">
            <Expression>LRG_1232p1:p.Lys9fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA125279" DB="ClinGen" />
        <XRef ID="GTR000500319" DB="Genetic Testing Registry (GTR)" />
        <XRef Type="Allelic variant" ID="141900.0322" DB="OMIM" />
        <XRef Type="rs" ID="35497102" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00002" Source="Exome Aggregation Consortium (ExAC)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000518.5(HBB):c.25_26del (p.Lys9fs) AND Beta zero thalassemia" Accession="RCV000016669" Version="34">
        <ClassifiedConditionList TraitSetID="4683">
          <ClassifiedCondition DB="MedGen" ID="C0271980">Beta zero thalassemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1995-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000518.5(HBB):c.25_26del (p.Lys9fs) AND beta Thalassemia" Accession="RCV000029972" Version="20">
        <ClassifiedConditionList TraitSetID="4697">
          <ClassifiedCondition DB="MedGen" ID="C0005283">beta Thalassemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2019-12-20" SubmissionCount="5">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000518.5(HBB):c.25_26del (p.Lys9fs) AND not provided" Accession="RCV000506563" Version="42">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-15" SubmissionCount="7">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000518.5(HBB):c.25_26del (p.Lys9fs) AND Hb SS disease" Accession="RCV001004358" Version="9">
        <ClassifiedConditionList TraitSetID="4606">
          <ClassifiedCondition DB="MedGen" ID="C0002895">Hb SS disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000518.5(HBB):c.25_26del (p.Lys9fs) AND Beta-thalassemia HBB/LCRB" Accession="RCV002288500" Version="10">
        <ClassifiedConditionList TraitSetID="80504">
          <ClassifiedCondition DB="MedGen" ID="CN322236">Beta-thalassemia HBB/LCRB</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-02-23" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000518.5(HBB):c.25_26del (p.Lys9fs) AND Malaria, susceptibility to" Accession="RCV003989287" Version="1">
        <ClassifiedConditionList TraitSetID="1954">
          <ClassifiedCondition DB="MedGen" ID="C1970028">Malaria, susceptibility to</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-29" NumberOfSubmissions="18" NumberOfSubmitters="18" DateCreated="2013-04-04" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11857746</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1390250</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15108284</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16311287</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1917531</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20437613</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20704537</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2200760</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22110956</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22851993</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23321370</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23637309</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2430648</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2446680</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25155404</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25405919</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26771086</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28391758</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">3683554</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">3828533</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">6162860</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">6280057</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">6292840</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">6310991</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">6985481</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7795641</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9140720</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://ithanet.eu/db/ithagenes?ithaID=61</URL>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301599</ID>
          <ID Source="BookShelf">NBK1426</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="4683" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="11956" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Beta zero thalassemia</ElementValue>
                <XRef ID="86715000" DB="SNOMED CT" />
              </Name>
              <Citation Type="practice guideline" Abbrev="ACMG ACT Sheet, 2023">
                <URL>https://www.acmg.net/PDFLibrary/Sickle-Cell-Anemia-HBss.pdf</URL>
                <CitationText>American College of Medical Genetics ACT SHEET, Sickle Cell Anemia, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/Hemoglobin-EE-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, FE, Hemoglobin EE or Hemoglobin E/Beta Zero Thalassemia (Hb EE or Hb E/ß0 Disease), 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/Beta-Thalassemia-Major-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Hemoglobin F-Only; Hemoglobin F With Decreased A, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2009">
                <URL>https://www.acmg.net/PDFLibrary/HB-Screening-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Hb Screening (non-S), 2009</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/Hemoglobin-FS-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, FS: Hemoglobin S Screening Result, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/Beta-Thalassemia-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, Hemoglobin F Only or F with Decreased A: Transfusion Dependent or Non Transfusion Dependent beta-Thalassemia; Hb beta 0 Thalassemia; Hb beta+/beta+ Thalassemia; Hb beta0/beta+ Thalassemia Screening Result, 2023</CitationText>
              </Citation>
              <XRef ID="C0271980" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="80504" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="65989" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Beta-thalassemia HBB/LCRB</ElementValue>
                <XRef ID="MONDO:0013517" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Beta-thalassemia (β-thalassemia) is characterized by reduced synthesis of the hemoglobin subunit beta (hemoglobin beta chain) that results in microcytic hypochromic anemia, an abnormal peripheral blood smear with nucleated red blood cells, and reduced amounts of hemoglobin A (HbA) on hemoglobin analysis. Individuals with thalassemia major have severe anemia and hepatosplenomegaly; they usually come to medical attention within the first two years of life. Without treatment, affected children have severe failure to thrive and shortened life expectancy. Treatment with a regular transfusion program and chelation therapy, aimed at reducing transfusion iron overload, allows for normal growth and development and may improve the overall prognosis. Individuals with thalassemia intermedia present later and have milder anemia that does not require regular treatment with blood transfusion. These individuals are at risk for iron overload secondary to increased intestinal absorption of iron as a result of ineffective erythropoiesis.</Attribute>
                <XRef ID="NBK1426" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301599</ID>
                <ID Source="BookShelf">NBK1426</ID>
              </Citation>
              <XRef ID="CN322236" DB="MedGen" />
              <XRef ID="MONDO:0013517" DB="MONDO" />
              <XRef Type="MIM" ID="613985" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="4606" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5915" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Sickle cell anemia</ElementValue>
                <XRef ID="MONDO:0011382" DB="MONDO" />
                <XRef ID="232" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hb SS disease</ElementValue>
                <XRef ID="127040003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sickle cell disease</ElementValue>
                <XRef ID="C34383" DB="NCI" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HbS disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hemoglobin S Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sickling disorder due to hemoglobin S</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SCD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8614" />
                <XRef ID="8614" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Sickle cell disease (SCD) is characterized by intermittent vaso-occlusive events and chronic hemolytic anemia. Vaso-occlusive events result in tissue ischemia leading to acute and chronic pain as well as organ damage that can affect any organ system, including the bones, spleen, liver, brain, lungs, kidneys, and joints. Dactylitis (pain and/or swelling of the hands or feet) is often the earliest manifestation of SCD. In children, the spleen can become engorged with blood cells in a "splenic sequestration." The spleen is particularly vulnerable to infarction and the majority of individuals with SCD who are not on hydroxyurea or transfusion therapy become functionally asplenic in early childhood, increasing their risk for certain types of bacterial infections, primarily encapsulated organisms. Acute chest syndrome (ACS) is a major cause of mortality in SCD. Chronic hemolysis can result in varying degrees of anemia, jaundice, cholelithiasis, and delayed growth and sexual maturation as well as activating pathways that contribute to the pathophysiology directly. Individuals with the highest rates of hemolysis are at higher risk for pulmonary artery hypertension, priapism, and leg ulcers and may be relatively protected from vaso-occlusive pain.</Attribute>
                <XRef ID="NBK1377" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301551</ID>
                <ID Source="BookShelf">NBK1377</ID>
              </Citation>
              <Citation Type="general" Abbrev="USPSTF, 2009">
                <ID Source="PubMed">19323364</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2006">
                <ID Source="pmc">3111605</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT Sheet, 2023">
                <URL>https://www.acmg.net/PDFLibrary/Sickle-Cell-Anemia-HBss.pdf</URL>
                <CitationText>American College of Medical Genetics ACT SHEET, Sickle Cell Anemia, 2023</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="Yawn et al., 2014">
                <ID Source="PubMed">25203083</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHA/ASA, 2014">
                <ID Source="PubMed">25355838</ID>
              </Citation>
              <Citation Type="general" Abbrev="EMQN, 2014">
                <ID Source="PubMed">25052315</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Sickle-Cell-Carrier-NBS-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics ACT SHEET, Newborn Screening ACT Sheet, [FAS] Sickle Cell Carrier (HbAS)</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2021">
                <ID Source="PubMed">17197616</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2009">
                <URL>https://www.acmg.net/PDFLibrary/HB-S-Screening-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Hb S Screening, 2009</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/Sickle-Cell-Carrier-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Carrier Screening ACT Sheet, Sickle Cell Carrier/Trait, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Sickle-Cell-Disease-Transition.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Transition to Adult Health Care ACT Sheet, Sickle Cell Disease, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/Hemoglobin-FS-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, FS: Hemoglobin S Screening Result, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/Hemoglobin-AS-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, FAS: Sickle Cell Trait Screening Result, 2023</CitationText>
              </Citation>
              <XRef ID="232" DB="Orphanet" />
              <XRef ID="C0002895" DB="MedGen" />
              <XRef ID="MONDO:0011382" DB="MONDO" />
              <XRef Type="MIM" ID="603903" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="4697" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="11970" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cooley's anemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Erythroblastic anemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mediterranean anemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">beta Thalassemia</ElementValue>
                <XRef ID="Beta+Thalassemia/814" DB="Genetic Alliance" />
                <XRef ID="65959000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BTHAL</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Beta-thalassemia (β-thalassemia) is characterized by reduced synthesis of the hemoglobin subunit beta (hemoglobin beta chain) that results in microcytic hypochromic anemia, an abnormal peripheral blood smear with nucleated red blood cells, and reduced amounts of hemoglobin A (HbA) on hemoglobin analysis. Individuals with thalassemia major have severe anemia and hepatosplenomegaly; they usually come to medical attention within the first two years of life. Without treatment, affected children have severe failure to thrive and shortened life expectancy. Treatment with a regular transfusion program and chelation therapy, aimed at reducing transfusion iron overload, allows for normal growth and development and may improve the overall prognosis. Individuals with thalassemia intermedia present later and have milder anemia that does not require regular treatment with blood transfusion. These individuals are at risk for iron overload secondary to increased intestinal absorption of iron as a result of ineffective erythropoiesis.</Attribute>
                <XRef ID="NBK1426" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="871" />
                <XRef ID="871" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000515560" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520044" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592332" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000567333" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520115" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596318" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000260581" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556525" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529085" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592333" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592286" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501908" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501909" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508856" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556526" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521590" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558937" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570317" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501386" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592287" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301599</ID>
                <ID Source="BookShelf">NBK1426</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2021">
                <ID Source="PubMed">17197616</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/Beta-Thalassemia-Major-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Hemoglobin F-Only; Hemoglobin F With Decreased A, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2009">
                <URL>https://www.acmg.net/PDFLibrary/HB-Screening-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Hb Screening (non-S), 2009</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/Hemoglobin-E-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, FEA, Hemoglobin E/Beta Plus Thalassemia, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/Beta-Thalassemia-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, Hemoglobin F Only or F with Decreased A: Transfusion Dependent or Non Transfusion Dependent beta-Thalassemia; Hb beta 0 Thalassemia; Hb beta+/beta+ Thalassemia; Hb beta0/beta+ Thalassemia Screening Result, 2023</CitationText>
              </Citation>
              <XRef ID="848" DB="Orphanet" />
              <XRef ID="C0005283" DB="MedGen" />
              <XRef ID="MONDO:0019402" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1954" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10300" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Malaria, susceptibility to</ElementValue>
                <XRef ID="MONDO:0021024" DB="MONDO" />
              </Name>
              <XRef ID="673" DB="Orphanet" />
              <XRef ID="C1970028" DB="MedGen" />
              <XRef ID="MONDO:0021024" DB="MONDO" />
              <XRef Type="MIM" ID="611162" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2292350" SubmissionDate="2019-09-27" DateLastUpdated="2020-03-01" DateCreated="2020-03-01">
        <ClinVarSubmissionID localKey="NC_000011.9:g.5248226_5248227delTT|OMIM:603903" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001163294" DateUpdated="2020-03-01" DateCreated="2020-03-01" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.5248226_5248227delTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="603903" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>BG_GA_2018_SNVs_INDELS</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2454040" SubmissionDate="2019-11-25" DateLastUpdated="2020-04-24" DateCreated="2020-04-24">
        <ClinVarSubmissionID localKey="ithaID:61|Orphanet:ORPHA:848" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001244554" DateUpdated="2020-04-24" DateCreated="2020-04-24" Type="SCV" Version="1" SubmitterName="The ITHANET community portal, The Cyprus Institute of Neurology and Genetics" OrgID="507248" OrganizationCategory="locus-specific database (LSDB)" OrgAbbreviation="ITHANET" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-11-25">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">6162860</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7795641</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>CD 8 (-AA)</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="dbSNP" ID="35497102" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000518.5:c.25_26del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">beta Thalassemia</ElementValue>
            </Name>
            <XRef DB="Orphanet" ID="ORPHA848" />
          </Trait>
        </TraitSet>
        <Citation>
          <URL>https://ithanet.eu/db/ithagenes?ithaID=61</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB6599191</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2354497" SubmissionDate="2020-06-18" DateLastUpdated="2020-07-03" DateCreated="2020-04-06">
        <ClinVarSubmissionID localKey="64|OMIM:613985" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001194042" DateUpdated="2020-07-03" DateCreated="2020-04-06" Type="SCV" Version="2" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000678156" DateChanged="2020-07-02" Version="2">
            <Comment Type="MergeComment">SCV000678156 was merged into SCV001194042 to remove duplication.</Comment>
          </Replaced>
        </ReplacedList>
        <Classification DateLastEvaluated="2019-12-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22851993</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25155404</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23321370</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2200760</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">6985481</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22110956</ID>
          </Citation>
          <Comment>NM_000518.4(HBB):c.25_26delAA(aka K9Vfs*14) is classified as pathogenic in the context of Hb beta chain-related hemoglobinopathy; it is associated with beta thalassemia and is classified as a beta-zero variant. Sources cited for classification include the following: PMID 22851993, 25155404, 23321370, 2200760, 6985481 and 22110956. Classification of NM_000518.4(HBB):c.25_26delAA(aka K9Vfs*14) is based on the following criteria: The variant causes a premature termination codon that is expected to be targeted by nonsense-mediated mRNA decay and is reported in individuals with the relevant phenotype. Please note: this variant was assessed in the context of healthy population screening.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2019)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/vlxza0ea/myriad_women_s_health_autosomal_recessive_and_x-linked_classification_criteria_2019_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="C" referenceAllele="CTT" start="5248225" stop="5248227" variantLength="3" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613985" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6849778</SubmissionName>
          <SubmissionName>SUB7605676</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2857084" SubmissionDate="2020-10-23" DateLastUpdated="2020-11-28" DateCreated="2020-11-28">
        <ClinVarSubmissionID localKey="report_configuration_variant_id:23069" />
        <ClinVarAccession Accession="SCV001446696" DateUpdated="2020-11-28" DateCreated="2020-11-28" Type="SCV" Version="1" SubmitterName="Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen" OrgID="506385" OrganizationCategory="laboratory" OrgAbbreviation="IMGAG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal unknown</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SampleLocalID">DX196954</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0007354" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001257" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001260" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002380" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0003202" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="C" referenceAllele="CTT" start="5248225" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="36939" SubmissionDate="2021-08-03" DateLastUpdated="2021-08-07" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="141900.0322_BETA-ZERO-THALASSEMIA" title="HBB, LYS8FS_BETA-ZERO-THALASSEMIA" />
        <ClinVarAccession Accession="SCV000036939" DateUpdated="2021-08-07" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1995-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">A frameshift mutation, -AA in codon 8, AAG to G, in the HBB gene was found in a Turkish patient with beta-zero-thalassemia (613985) by Orkin and Goff (1981). This mutation was also found in homozygous state in DNA from the archaeologic remains of a child with severe bone pathology consistent with thalassemia (Filon et al., 1995). The remains came from a grave thought to date to the Ottoman period, sometime between the 16th and 19th centuries. From the tooth development, it was estimated that the child died at the age of about 8 years, whereas patients with this mutation would be expected to be transfusion-dependent from early infancy. Filon et al. (1995) also found a rare DNA polymorphism: a C-to-T transition in the second codon of the HBB gene that did not alter the corresponding amino acid. This polymorphism is found in 13% of present-day Mediterranean beta-thalassemia chromosomes and is part of a haplotype (haplotype IV) that is associated with relatively high levels of fetal hemoglobin. The disease may have run a milder course because of linkage to haplotype IV.</Attribute>
              <Citation>
                <ID Source="PubMed">6985481</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">7795641</ID>
              </Citation>
              <XRef DB="OMIM" ID="613985" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBB" />
          </GeneList>
          <Name>HBB, LYS8FS</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">LYS8FS</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="141900.0322" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">BETA-ZERO-THALASSEMIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1164956" SubmissionDate="2017-08-01" DateLastUpdated="2022-01-01" DateCreated="2017-09-30">
        <ClinVarSubmissionID localKey="NM_000518.4:c.25_26del|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000601261" DateUpdated="2022-01-01" DateCreated="2017-09-30" Type="SCV" Version="2" SubmitterName="Quest Diagnostics Nichols Institute San Juan Capistrano" OrgID="500110" OrganizationCategory="laboratory" OrgAbbreviation="Quest Diagnostics" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-11-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">6985481</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">6280057</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2430648</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">3828533</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7795641</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Quest Diagnostics criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.Lys9Valfs*14</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000518.4:c.25_26del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2915479</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="56777" SubmissionDate="2011-08-18" DateLastUpdated="2022-04-11" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="HBB_25_26delAA_020311" title="HBB:c.25_26delAA and Beta Thalassemia" />
        <ClinVarAccession Accession="SCV000052627" DateUpdated="2022-04-11" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-08-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">20704537</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">6310991</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">20437613</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">6292840</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">2200760</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">15108284</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">1917531</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">9140720</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">11857746</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">1390250</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">2446680</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">3683554</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">16311287</ID>
          </Citation>
          <Comment>Converted during submission to Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">autosomal recessive</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>10</NumberTested>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="20" />
              <Comment>This is a review which lists the variant as a common DV in Middle Eastern populations; the numbers entered here were fabricated in order to push the score to -3, since this is a known common DV.</Comment>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Tissue>Blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>assert pathogenicity</Purpose>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles">1</Attribute>
            </ObservedData>
            <Co-occurrenceSet>
              <Zygosity>SingleHeterozygote</Zygosity>
              <AlleleDescSet>
                <Name>HBB:c.9T&gt;C</Name>
                <Zygosity>SingleHeterozygote</Zygosity>
              </AlleleDescSet>
              <AlleleDescSet>
                <Name>HBB:c.316-185C&gt;T</Name>
                <Zygosity>SingleHeterozygote</Zygosity>
              </AlleleDescSet>
              <AlleleDescSet>
                <Name>HBB:c.315+16G&gt;C</Name>
                <Zygosity>SingleHeterozygote</Zygosity>
              </AlleleDescSet>
              <Count>1</Count>
            </Co-occurrenceSet>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Tissue>Blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>assert pathogenicity</Purpose>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles">1</Attribute>
            </ObservedData>
            <Co-occurrenceSet>
              <Zygosity>SingleHeterozygote</Zygosity>
              <AlleleDescSet>
                <Name>HBB:c.9T&gt;C</Name>
                <Zygosity>SingleHeterozygote</Zygosity>
              </AlleleDescSet>
              <AlleleDescSet>
                <Name>HBB:c.316-185C&gt;T</Name>
                <Zygosity>SingleHeterozygote</Zygosity>
              </AlleleDescSet>
              <AlleleDescSet>
                <Name>HBB:c.315+16G&gt;C</Name>
                <Zygosity>SingleHeterozygote</Zygosity>
              </AlleleDescSet>
              <Count>1</Count>
            </Co-occurrenceSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBB" />
          </GeneList>
          <VariantType>single nucleotide variant</VariantType>
          <MolecularConsequenceList>
            <MolecularConsequence Function="frameshift mutation">
              <XRef DB="Sequence Ontology" ID="SO:0000865" />
            </MolecularConsequence>
          </MolecularConsequenceList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000518.4:c.25_26delAA</Attribute>
          </AttributeSet>
          <AttributeSet>
            <Attribute Type="HGVS">p.Lys9ValfsX14</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Beta Thalassemia</ElementValue>
            </Name>
            <Symbol>
              <ElementValue Type="Preferred">BTHAL</ElementValue>
            </Symbol>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="40706" SubmissionDate="2022-04-01" DateLastUpdated="2022-10-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="NM_000518.4:c.25_26delAA|OMIM:613985" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000040706" DateUpdated="2022-10-01" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="BookShelf">NBK1426</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000518.4:c.25_26delAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0005283" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11264553</SubmissionName>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5041821" SubmissionDate="2022-10-06" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="NM_000518.5:c.25_26del|OMIM:613985" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002581330" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="MGZ Medical Genetics Center" OrgID="255845" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="35497102" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000518.5:c.25_26del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613985" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>ACMG criteria applied: PVS1, PS4_MOD, PM3, PM2_SUP, PP4</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB12035528</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5502605" SubmissionDate="2022-12-17" DateLastUpdated="2023-01-07" DateCreated="2023-01-07">
        <ClinVarSubmissionID localKey="NM_000518.5:c.25_26del|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002818122" DateUpdated="2023-01-07" DateCreated="2023-01-07" Type="SCV" Version="1" SubmitterName="Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital" OrgID="507199" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000518.5:c.25_26del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12445851</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7564528" SubmissionDate="2023-10-09" DateLastUpdated="2023-10-14" DateCreated="2023-10-14">
        <ClinVarSubmissionID localKey="NM_000518.5:c.25_26del|OMIM:613985" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004041636" DateUpdated="2023-10-14" DateCreated="2023-10-14" Type="SCV" Version="1" SubmitterName="Zotz-Klimas Genetics Lab, MVZ Zotz Klimas" OrgID="507243" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-09">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000518.5:c.25_26del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613985" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13890390</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2284764" SubmissionDate="2024-01-24" DateLastUpdated="2024-02-20" DateCreated="2020-02-10">
        <ClinVarSubmissionID localKey="3421200|MedGen:CN235283" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001160183" DateUpdated="2024-02-20" DateCreated="2020-02-10" Type="SCV" Version="6" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The HBB c.25_26del; p.Lys9ValfsTer14 variant (also known as Lys8fsTer14 when numbered from the mature protein or as Codon 8 (-AA), rs35497102, Hbvar ID: 785) has been reported in multiple patients with beta (0) thalassemia, both in the homozygous state and in trans to another pathogenic variant (Jalilian 2017, Orkin 1981, HbVar database and references therein). This variant is found on only two chromosomes in the Genome Aggregation Database, indicating it is not a common polymorphism. This variant causes a frameshift by deleting two nucleotides, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. References: Link to HbVar database: https://globin.bx.psu.edu/hbvar/hbvar.html Jalilian M et al. The Frequency of HBB Mutations Among beta-Thalassemia Patients in Hamadan Province, Iran. Hemoglobin. 2017 Jan;41(1):61-64. PMID: 28391758. Orkin S et al. Nonsense and frameshift mutations in beta 0-thalassemia detected in cloned beta-globin genes. J Biol Chem. 1981; 256(19):9782-4. PMID: 6985481.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process 2024</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/xwiqgyug/arup_molecular_germline_variant_investigation_process_arup-info-0022_2024.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.5248226_5248227del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN235283" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2020 ARUP</SubmissionName>
          <SubmissionName>2022 ARUP ClinVar submission</SubmissionName>
          <SubmissionName>2023 ARUP ClinVar submission</SubmissionName>
          <SubmissionName>ARUP Molecular 2021</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8988064" SubmissionDate="2024-03-29" DateLastUpdated="2024-04-06" DateCreated="2024-04-06">
        <ClinVarSubmissionID localKey="NM_000518.5:c.25_26del|OMIM:611162" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004807714" DateUpdated="2024-04-06" DateCreated="2024-04-06" Type="SCV" Version="1" SubmitterName="Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center" OrgID="508075" OrganizationCategory="other" OrgAbbreviation="CGM_KFSHRC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000518.5:c.25_26del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="611162" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14345717</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2863185" SubmissionDate="2020-11-26" DateLastUpdated="2020-12-10" DateCreated="2020-12-10">
        <ClinVarSubmissionID localKey="NM_000518.5:c.25_26del|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001450319" DateUpdated="2020-12-10" DateCreated="2020-12-10" Type="SCV" Version="1" SubmitterName="Clinical Genetics and Genomics, Karolinska University Hospital" OrgID="505315" OrganizationCategory="laboratory" OrgAbbreviation="KLINGEN-KUS" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-03-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="17" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000518.5:c.25_26del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8639822</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4079467" SubmissionDate="2022-02-09" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NM_000518.5:c.25_26del|Beta thalassemia" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002091612" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-17">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000518.5:c.25_26del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Beta thalassemia</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7171381" SubmissionDate="2023-03-09" DateLastUpdated="2023-03-18" DateCreated="2023-03-18">
        <ClinVarSubmissionID localKey="11-5248225-CTT-C" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003841708" DateUpdated="2023-03-18" DateCreated="2023-03-18" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">3828533</ID>
          </Citation>
          <Comment>The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: &lt;0.001%). This variant was predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000015413 / PMID: 3828533). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0011906" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0004322" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001510" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001508" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0004325" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002653" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000518.5:c.25_26del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613985" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12919228</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1847317" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="4733351|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000953169" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23637309</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">3828533</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25405919</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26771086</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28391758</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Lys9Valfs*14) in the HBB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HBB are known to be pathogenic (PMID: 23637309). This variant is present in population databases (rs35497102, gnomAD 0.007%). This premature translational stop signal has been observed in individuals with HBB-related conditions (PMID: 3828533, 25405919, 26771086, 28391758). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 15413). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.5248226_5248227del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3849573" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2021-10-08">
        <ClinVarSubmissionID localKey="109648|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001961264" DateUpdated="2024-07-15" DateCreated="2021-10-08" Type="SCV" Version="17" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>HBB: PVS1, PS4:Moderate</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="4" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="C" referenceAllele="CTT" start="5248225" stop="5248227" variantLength="3" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7171381" TraitType="Finding" MappingType="XRef" MappingValue="HP:0004325" MappingRef="HP">
        <MedGen CUI="C5574742" Name="Decreased body weight" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7171381" TraitType="Finding" MappingType="XRef" MappingValue="HP:0004322" MappingRef="HP">
        <MedGen CUI="C0349588" Name="Short stature" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1164956" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3849573" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2354497" TraitType="Disease" MappingType="XRef" MappingValue="613985" MappingRef="OMIM">
        <MedGen CUI="CN322236" Name="Beta-thalassemia HBB/LCRB" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2857084" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002380" MappingRef="HP">
        <MedGen CUI="C0015644" Name="Fasciculations" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5041821" TraitType="Disease" MappingType="XRef" MappingValue="613985" MappingRef="OMIM">
        <MedGen CUI="CN322236" Name="Beta-thalassemia HBB/LCRB" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="36939" TraitType="Disease" MappingType="Name" MappingValue="BETA-ZERO-THALASSEMIA" MappingRef="Preferred">
        <MedGen CUI="C0271980" Name="Beta zero thalassemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7171381" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011906" MappingRef="HP">
        <MedGen CUI="C4023137" Name="Reduced beta/alpha synthesis ratio" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8988064" TraitType="Disease" MappingType="XRef" MappingValue="611162" MappingRef="OMIM">
        <MedGen CUI="C1970028" Name="Malaria, susceptibility to" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1847317" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2857084" TraitType="Finding" MappingType="XRef" MappingValue="HP:0007354" MappingRef="HP">
        <MedGen CUI="C0002736" Name="Amyotrophic lateral sclerosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5502605" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7171381" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002653" MappingRef="HP">
        <MedGen CUI="C0151825" Name="Bone pain" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7171381" TraitType="Disease" MappingType="XRef" MappingValue="613985" MappingRef="OMIM">
        <MedGen CUI="CN322236" Name="Beta-thalassemia HBB/LCRB" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2857084" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001257" MappingRef="HP">
        <MedGen CUI="C0026838" Name="Spasticity" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7564528" TraitType="Disease" MappingType="XRef" MappingValue="613985" MappingRef="OMIM">
        <MedGen CUI="CN322236" Name="Beta-thalassemia HBB/LCRB" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2454040" TraitType="Disease" MappingType="Name" MappingValue="beta Thalassemia" MappingRef="Preferred">
        <MedGen CUI="C0005283" Name="beta Thalassemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2857084" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4079467" TraitType="Disease" MappingType="Name" MappingValue="Beta thalassemia" MappingRef="Preferred">
        <MedGen CUI="C0005283" Name="beta Thalassemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="40706" TraitType="Disease" MappingType="XRef" MappingValue="C0005283" MappingRef="MedGen">
        <MedGen CUI="C0005283" Name="beta Thalassemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7171381" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001508" MappingRef="HP">
        <MedGen CUI="C2315100" Name="Failure to thrive" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2857084" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001260" MappingRef="HP">
        <MedGen CUI="C0013362" Name="Dysarthria" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2284764" TraitType="Disease" MappingType="XRef" MappingValue="CN235283" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2292350" TraitType="Disease" MappingType="XRef" MappingValue="603903" MappingRef="OMIM">
        <MedGen CUI="C0002895" Name="Hb SS disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2863185" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2857084" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003202" MappingRef="HP">
        <MedGen CUI="C0541794" Name="Muscular atrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7171381" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001510" MappingRef="HP">
        <MedGen CUI="C0456070" Name="Growth delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="56777" TraitType="Disease" MappingType="Name" MappingValue="Beta Thalassemia" MappingRef="Preferred">
        <MedGen CUI="C0005283" Name="beta Thalassemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

